EMBED CODE (Copy and Paste)
The multiple myeloma market will witness an impressive 10% annual growth over 2015-2025, with major-market sales increasing from $8.6 billion in 2015 to $22.3 billion in 2025. Growth will be fueled by the continued uptake and label expansions of current therapies and the expected market entry of four novel, premium-priced therapies. Immunomodulatory agents are, and will remain, the dominant drug class throughout the forecast period and will capture more than 50% of major-market sales in 2025. Got a question about the product? Email us at [email protected] or ask the author directly by using the form to the right. If you cannot view the preview above this document description, go here to view the large preview instead. Source: Pharma Disease Insights: Multiple Myeloma PowerPoint document
This document is available as part of the following discount bundle(s):
|
Pharma Disease Insights: Multiple MyelomaSold by BigPharma2000 (this author has 41 documents)
This business document is categorized under the function(s): It applies to Healthcare & Life Sciences File Type: PowerPoint File Size: 1.9 MB Number of Slides: 29 (includes cover, transition slides) Related Topic(s): Cancer Purchase includes lifetime product updates. After your purchase, you will receive an email to download this document. Initial upload date (first version): Jun 8, 2017 Ask the Author a Question Must be logged in Click here to log in ![]() ![]() |
SELECT CUSTOMERS
|
Since 2012, we have provided best practices to over 5,000 businesses and organizations of all sizes across the world—in over 130 countries. Below is just a very small sample of our customer base. |
![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() |
![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() |
CUSTOMERS ALSO BOUGHT THESE DOCUMENTS
|
RELATED TOPICS
TOP 10 TOPICS
|